strong fundamentals, page-5

I actually think the Board members should all purchase some shares in the next few weeks which would show their own support for the company plus earn some respect back from the shareholders.
As long as it was within the limits of when they are allowed to purchase as in no imminent news due out like maybe after next week when I assume we will get an update about what occurred overseas & if Nova is going to wait for the end of the increased dosing trial results I see that as a prime time for the board to buy shares themselves & maybe ask for some performance ones later on?

It would be smart of Nova to make an opportunistic offer now but don't know if this would blow their once only 60 day right of refusal chance away or also they may have to wait for the next trials for their own justification to their shareholders too - both sides are very antsy to get this drug commercialised so I suppose we'll hear next week what the outcome of the presentation overseas was.

If we'd waited until this week would have saved $150k on buying our extra shares - usually our rule is it's better to pay a premium on confirmation rather than speculate but anyway a lesson to others to stick to their usual rules!
We will be buying more once we see what next news entails.

I'm sure the price would have fallen this week with all the market blues but not down to this level even (which is holding well though with constant 200k buyers coming in)
When you understand the results properly & the method they were trialing then you can see how their ASX report was not properly written nor understood in the first place.
That Biotechnology website had the sense to see & report the positives as it should have been presented.

All we can do is hang on & see what next week brings (& find extra cash to take advantage of this 'opportunity'!)